Xadago
Chemical Name | safinamide |
Dosage Form | Tablet (oral; 50 mg, 100 mg) |
Drug Class | Inhibitors |
System | Musculoskeletal, Nervous |
Company | Supernus Pharmaceuticals |
Approval Year | 2017 |
Indication
- Indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes